Changing what it means to grow older

We work on shared challenges in the science of immunity and aging. Our ambition is longer, healthier lives for more people.

Immune Cell
Cancer Cell

What We Do

The Immune-Aging Project is a global non-profit focused on shared challenges that influence progress in immune-aging field.

Laboratories, clinicians, companies, funders, and non-profits all contribute to the advancement of immune-aging science. Many challenges that shape progress are shared across organizations rather than confined to any single one.

These include how knowledge is shared, how evidence is interpreted, and how findings remain meaningful as the field evolves.

Our work is organized through two programs:

How We Know

The act of finding, not just the finding, is worth sharing.

Explore How We Know →

Continuum

Building the foundations for immune-aging evidence to remain meaningful across time and populations.

A stylized abstract image representing the flow of scientific data

Latest from the project

Alain Fischer, featured in the full Burstcast conversation
Alain Fischer
Full Burstcast

Alain Fischer on gene therapy and immune restoration

Watch the full Burstcast on gene therapy for inherited immune deficiencies, with Alain Fischer, Amit Agrawal, and Julia Majewska.

Watch the full Burstcast 
FellowshipApply by 8 November

Applications open for our second fellowship cohort

Three months of guided practice in science communication, starting 23 November 2026.

Explore the English cohort 
Programme launchHow We Know

Introducing the Italian fellowship cohort

A new cohort for fellows creating science communication in Italian, with teaching in English.

Explore the Italian cohort 
PeopleItalian cohort

Giuseppina Lambiase leads the Italian cohort

A fellow from our first cohort, Pina will help guide the next group’s science communication projects.

Meet the cohort lead 
All updates

Our Thinking: The Collaborative Science of Longevity

Late-life health loss often attributed to aging is not our inevitable fate. We believe that by elucidating the fundamental mechanisms of immune aging, we can translate that biology into actionable interventions and engineer a future of healthy longevity.

To achieve this, we believe in a community-driven approach. Finding the right collaborator (whether a cross-disciplinary researcher, a funder, or an industry partner) is like finding a substrate for an enzyme.

We aim to facilitate collaborative science and data sharing to help each other overcome bottlenecks in scientific work and bring fundamental science and industry work together.

The 2026 Burstcast Series

Rafi Ahmed
JAN

Immune Memory

The Architecture of Immune Memory

Defining T cell exhaustion and the stem-like subsets that sustain immunity in cancer and chronic infection.

Rafi Ahmed, Ph.D.

Professor, Emory University

→
Joan Mannick
FEB

Clinical Immunology

Targeting mTOR for Immune Resilience

Developing mTOR inhibitors to enhance the function of the aging immune system and improve vaccine response.

Joan Mannick, M.D.

CMO, Altos Labs

→
Alain Fischer
JUN

Immune Restoration

Gene Therapy for Primary Immunodeficiencies

Human gene therapy of hematopoietic progenitors harnesses the selective advantage to restore a functional immune system.

Alain Fischer, M.D., Ph.D.

Professor, Collège de France

→
Join the Community →

Leadership

The Immune-Aging Project is led by scientists with experience spanning aging biology, immunology, and program development.

Amit Agrawal

Amit Agrawal, Ph.D.

Executive Director

An aging biologist and engineer whose work combines experimental biology, quantitative analysis, and systems thinking. His research at the Weizmann Institute showed that senescent cells become harder for the body to remove with age, identified a PD-L1-based mechanism that helps them evade immune surveillance, and characterized the diversity of senescent cells that arise naturally in tissues.

Julia Magdalena Majewska

Julia Magdalena Majewska, Ph.D.

Scientific Program Director

An immuno-oncologist at INSERM bridging the gap between cancer biology and aging. Her research at the Weizmann Institute of Science demonstrated that senescent cells hijack the PD-L1 checkpoint to evade clearance, establishing a direct therapeutic link between cancer immunotherapy and longevity science.

Get Involved

Find your part in the work.

Develop your craft

Tell the story of scientific work in your own way through videos for social media, with scientific and editorial guidance.

Explore the fellowship

Support the institution

Help build an institution that serves the wider field of immune-aging science. Contact us to discuss where you or your organization could contribute.

Discuss supporting the project